HCA HEALTHCARE INC (HCA) Fundamental Analysis & Valuation

NYSE:HCA • US40412C1018

Current stock price

471.85 USD
-8.47 (-1.76%)
At close:
471.85 USD
0 (0%)
After Hours:

This HCA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. HCA Profitability Analysis

1.1 Basic Checks

  • HCA had positive earnings in the past year.
  • In the past year HCA had a positive cash flow from operations.
  • Each year in the past 5 years HCA has been profitable.
  • In the past 5 years HCA always reported a positive cash flow from operatings.
HCA Yearly Net Income VS EBIT VS OCF VS FCFHCA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of HCA (11.17%) is better than 95.00% of its industry peers.
  • The Return On Invested Capital of HCA (21.20%) is better than 95.00% of its industry peers.
  • HCA had an Average Return On Invested Capital over the past 3 years of 19.10%. This is significantly above the industry average of 8.85%.
  • The 3 year average ROIC (19.10%) for HCA is below the current ROIC(21.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.17%
ROE N/A
ROIC 21.2%
ROA(3y)10.06%
ROA(5y)10.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.1%
ROIC(5y)18.5%
HCA Yearly ROA, ROE, ROICHCA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.97%, HCA belongs to the top of the industry, outperforming 93.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of HCA has grown nicely.
  • HCA has a Operating Margin of 15.83%. This is amongst the best in the industry. HCA outperforms 94.00% of its industry peers.
  • In the last couple of years the Operating Margin of HCA has grown nicely.
  • HCA's Gross Margin of 84.96% is amongst the best of the industry. HCA outperforms 97.00% of its industry peers.
  • HCA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.83%
PM (TTM) 8.97%
GM 84.96%
OM growth 3Y1.74%
OM growth 5Y2.35%
PM growth 3Y-1.43%
PM growth 5Y4.26%
GM growth 3Y0.21%
GM growth 5Y0.29%
HCA Yearly Profit, Operating, Gross MarginsHCA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. HCA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HCA is creating value.
  • The number of shares outstanding for HCA has been reduced compared to 1 year ago.
  • Compared to 5 years ago, HCA has less shares outstanding
  • Compared to 1 year ago, HCA has a worse debt to assets ratio.
HCA Yearly Shares OutstandingHCA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
HCA Yearly Total Debt VS Total AssetsHCA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • The Debt to FCF ratio of HCA is 6.04, which is on the high side as it means it would take HCA, 6.04 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of HCA (6.04) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.04
Altman-Z N/A
ROIC/WACC2.58
WACC8.22%
HCA Yearly LT Debt VS Equity VS FCFHCA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 0.97 indicates that HCA may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.97, HCA is doing worse than 75.00% of the companies in the same industry.
  • A Quick Ratio of 0.86 indicates that HCA may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.86, HCA is doing worse than 74.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.86
HCA Yearly Current Assets VS Current LiabilitesHCA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. HCA Growth Analysis

3.1 Past

  • HCA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.30%, which is quite impressive.
  • Measured over the past years, HCA shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.50% on average per year.
  • The Revenue has been growing slightly by 7.08% in the past year.
  • The Revenue has been growing slightly by 7.97% on average over the past years.
EPS 1Y (TTM)28.3%
EPS 3Y18.86%
EPS 5Y23.5%
EPS Q2Q%44.58%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y7.87%
Revenue growth 5Y7.97%
Sales Q2Q%6.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.36% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.48% on average over the next years.
EPS Next Y7.58%
EPS Next 2Y8.92%
EPS Next 3Y10.2%
EPS Next 5Y12.36%
Revenue Next Year3.82%
Revenue Next 2Y4.36%
Revenue Next 3Y4.82%
Revenue Next 5Y5.48%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HCA Yearly Revenue VS EstimatesHCA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
HCA Yearly EPS VS EstimatesHCA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

More info and screens

Find the best growth stocksShow best growing peers

5

4. HCA Valuation Analysis

4.1 Price/Earnings Ratio

  • HCA is valuated correctly with a Price/Earnings ratio of 16.63.
  • Based on the Price/Earnings ratio, HCA is valued a bit cheaper than 73.00% of the companies in the same industry.
  • HCA is valuated rather cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 15.45, which indicates a correct valuation of HCA.
  • HCA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HCA is cheaper than 72.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. HCA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.63
Fwd PE 15.45
HCA Price Earnings VS Forward Price EarningsHCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HCA indicates a somewhat cheap valuation: HCA is cheaper than 73.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, HCA is valued a bit cheaper than 74.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.71
EV/EBITDA 9.75
HCA Per share dataHCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HCA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.19
PEG (5Y)0.71
EPS Next 2Y8.92%
EPS Next 3Y10.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HCA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.65%, HCA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.50, HCA pays a better dividend. On top of this HCA pays more dividend than 82.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, HCA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.65%

5.2 History

  • On average, the dividend of HCA grows each year by 44.46%, which is quite nice.
  • HCA has been paying a dividend for at least 10 years, so it has a reliable track record.
  • HCA has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)44.46%
Div Incr Years4
Div Non Decr Years4
HCA Yearly Dividends per shareHCA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • HCA pays out 10.01% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of HCA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP10.01%
EPS Next 2Y8.92%
EPS Next 3Y10.2%
HCA Yearly Income VS Free CF VS DividendHCA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
HCA Dividend Payout.HCA Dividend Payout, showing the Payout Ratio.HCA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HCA Fundamentals: All Metrics, Ratios and Statistics

HCA HEALTHCARE INC

NYSE:HCA (3/27/2026, 8:23:13 PM)

After market: 471.85 0 (0%)

471.85

-8.47 (-1.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-27
Earnings (Next)04-24
Inst Owners62%
Inst Owner Change-1.32%
Ins Owners1.29%
Ins Owner Change-50.98%
Market Cap105.49B
Revenue(TTM)75.60B
Net Income(TTM)6.78B
Analysts74.84
Price Target551.68 (16.92%)
Short Float %2.34%
Short Ratio3.16
Dividend
Industry RankSector Rank
Dividend Yield 0.65%
Yearly Dividend2.84
Dividend Growth(5Y)44.46%
DP10.01%
Div Incr Years4
Div Non Decr Years4
Ex-Date03-17
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.3%
Min EPS beat(2)8.05%
Max EPS beat(2)20.55%
EPS beat(4)4
Avg EPS beat(4)11.83%
Min EPS beat(4)8.05%
Max EPS beat(4)20.55%
EPS beat(8)6
Avg EPS beat(8)8.6%
EPS beat(12)9
Avg EPS beat(12)8.06%
EPS beat(16)11
Avg EPS beat(16)6.36%
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)2.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)2.2%
Revenue beat(8)3
Avg Revenue beat(8)0.16%
Revenue beat(12)7
Avg Revenue beat(12)0.68%
Revenue beat(16)8
Avg Revenue beat(16)0.33%
PT rev (1m)1.02%
PT rev (3m)12.54%
EPS NQ rev (1m)-0.35%
EPS NQ rev (3m)0.58%
EPS NY rev (1m)0.7%
EPS NY rev (3m)1.82%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-0.53%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 16.63
Fwd PE 15.45
P/S 1.4
P/FCF 13.71
P/OCF 8.35
P/B N/A
P/tB N/A
EV/EBITDA 9.75
EPS(TTM)28.38
EY6.01%
EPS(NY)30.53
Fwd EY6.47%
FCF(TTM)34.41
FCFY7.29%
OCF(TTM)56.52
OCFY11.98%
SpS338.15
BVpS-26.96
TBVpS-73
PEG (NY)2.19
PEG (5Y)0.71
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 11.17%
ROE N/A
ROCE 26.97%
ROIC 21.2%
ROICexc 21.71%
ROICexgc 28.48%
OM 15.83%
PM (TTM) 8.97%
GM 84.96%
FCFM 10.17%
ROA(3y)10.06%
ROA(5y)10.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.1%
ROIC(5y)18.5%
ROICexc(3y)19.68%
ROICexc(5y)19.06%
ROICexgc(3y)25.77%
ROICexgc(5y)29.22%
ROCE(3y)24.29%
ROCE(5y)23.53%
ROICexgc growth 3Y-3.7%
ROICexgc growth 5Y-0.21%
ROICexc growth 3Y8.29%
ROICexc growth 5Y7.06%
OM growth 3Y1.74%
OM growth 5Y2.35%
PM growth 3Y-1.43%
PM growth 5Y4.26%
GM growth 3Y0.21%
GM growth 5Y0.29%
F-Score7
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.04
Debt/EBITDA 2.69
Cap/Depr 140.34%
Cap/Sales 6.54%
Interest Coverage 5.42
Cash Conversion 81.59%
Profit Quality 113.38%
Current Ratio 0.97
Quick Ratio 0.86
Altman-Z N/A
F-Score7
WACC8.22%
ROIC/WACC2.58
Cap/Depr(3y)147.23%
Cap/Depr(5y)143.02%
Cap/Sales(3y)6.92%
Cap/Sales(5y)6.83%
Profit Quality(3y)100.23%
Profit Quality(5y)90.24%
High Growth Momentum
Growth
EPS 1Y (TTM)28.3%
EPS 3Y18.86%
EPS 5Y23.5%
EPS Q2Q%44.58%
EPS Next Y7.58%
EPS Next 2Y8.92%
EPS Next 3Y10.2%
EPS Next 5Y12.36%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y7.87%
Revenue growth 5Y7.97%
Sales Q2Q%6.72%
Revenue Next Year3.82%
Revenue Next 2Y4.36%
Revenue Next 3Y4.82%
Revenue Next 5Y5.48%
EBIT growth 1Y13.44%
EBIT growth 3Y9.74%
EBIT growth 5Y10.5%
EBIT Next Year33.76%
EBIT Next 3Y13.94%
EBIT Next 5Y10.71%
FCF growth 1Y36.41%
FCF growth 3Y23.07%
FCF growth 5Y3.76%
OCF growth 1Y20.18%
OCF growth 3Y14.03%
OCF growth 5Y6.48%

HCA HEALTHCARE INC / HCA Fundamental Analysis FAQ

What is the fundamental rating for HCA stock?

ChartMill assigns a fundamental rating of 5 / 10 to HCA.


What is the valuation status of HCA HEALTHCARE INC (HCA) stock?

ChartMill assigns a valuation rating of 5 / 10 to HCA HEALTHCARE INC (HCA). This can be considered as Fairly Valued.


What is the profitability of HCA stock?

HCA HEALTHCARE INC (HCA) has a profitability rating of 9 / 10.


What is the financial health of HCA HEALTHCARE INC (HCA) stock?

The financial health rating of HCA HEALTHCARE INC (HCA) is 2 / 10.


Can you provide the expected EPS growth for HCA stock?

The Earnings per Share (EPS) of HCA HEALTHCARE INC (HCA) is expected to grow by 7.58% in the next year.